PH24214A - Lipid regulating composition - Google Patents

Lipid regulating composition

Info

Publication number
PH24214A
PH24214A PH37055A PH37055A PH24214A PH 24214 A PH24214 A PH 24214A PH 37055 A PH37055 A PH 37055A PH 37055 A PH37055 A PH 37055A PH 24214 A PH24214 A PH 24214A
Authority
PH
Philippines
Prior art keywords
lipid regulating
regulating composition
lipid
regulating
bezafibrate
Prior art date
Application number
PH37055A
Other languages
English (en)
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PH24214A publication Critical patent/PH24214A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S260/00—Chemistry of carbon compounds
    • Y10S260/47—Poisons, foods, or pharmaceuticals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH37055A 1987-06-15 1988-06-10 Lipid regulating composition PH24214A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/061,641 US4859703A (en) 1987-06-15 1987-06-15 Lipid regulating compositions

Publications (1)

Publication Number Publication Date
PH24214A true PH24214A (en) 1990-04-10

Family

ID=22037126

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37055A PH24214A (en) 1987-06-15 1988-06-10 Lipid regulating composition

Country Status (10)

Country Link
US (1) US4859703A (ja)
EP (1) EP0295637B1 (ja)
JP (1) JPS6419016A (ja)
AT (1) ATE67663T1 (ja)
AU (1) AU602769B2 (ja)
DE (1) DE3865102D1 (ja)
DK (1) DK323388A (ja)
NZ (1) NZ224669A (ja)
PH (1) PH24214A (ja)
ZA (1) ZA883623B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US5422372A (en) * 1990-04-10 1995-06-06 The Trustees Of Columbia University In The City Of New York Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol
EP0462067A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil formulations
WO1993003716A1 (en) * 1991-08-19 1993-03-04 The Trustees Of Columbia University In The City Of New York Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol
US7071174B1 (en) * 1994-10-13 2006-07-04 Cv Therapeutics, Inc. Method and composition for inhibiting cholesterol esterase
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
US6713043B2 (en) * 1996-02-29 2004-03-30 The Trustees Of Columbia University In The City Of New York Antimicrobial activity of gemfibrozil
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US6719999B2 (en) * 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6531291B1 (en) 1999-11-10 2003-03-11 The Trustees Of Columbia University In The City Of New York Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
GB2373438A (en) * 2001-02-10 2002-09-25 Reckitt & Colmann Prod Ltd Cholesterol lowering compositions
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US3907792A (en) * 1969-01-31 1975-09-23 Andre Mieville Phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US3781327A (en) * 1970-12-10 1973-12-25 Stauffer Chemical Co Meta-carbanilate ethers
BE792421A (fr) * 1971-12-11 1973-06-07 Merck Patent Gmbh Agent pour le traitement des hyperlipoproteinemies et son procede de preparation
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4751026A (en) * 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase

Also Published As

Publication number Publication date
EP0295637B1 (en) 1991-09-25
NZ224669A (en) 1990-06-26
EP0295637A3 (en) 1990-03-14
US4859703A (en) 1989-08-22
DK323388D0 (da) 1988-06-14
AU602769B2 (en) 1990-10-25
ZA883623B (en) 1990-01-31
ATE67663T1 (de) 1991-10-15
DE3865102D1 (de) 1991-10-31
EP0295637A2 (en) 1988-12-21
DK323388A (da) 1988-12-16
AU1641988A (en) 1988-12-15
JPS6419016A (en) 1989-01-23

Similar Documents

Publication Publication Date Title
PH24214A (en) Lipid regulating composition
GR3007225T3 (ja)
ES2042725T3 (es) Procedimiento para preparar inhibidores de 5-alfa-estersa de esteroide.
EP0225608A3 (de) Arzneimittel
IL84790A (en) Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
WO1988005296A3 (en) Lpid regulating compositions
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
GR3001277T3 (en) Chlorpheniramine therapy
IL75186A0 (en) Biologically active agents containing substituted isoxazolidines,certain such novel compounds and their preparation
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
TR25423A (tr) DAHA AKTIF TüRLERI BAKIMINDAN ZENGINLESTIRILMIS SIPERMETRIN VEYA SIFLUTRIN ISOMERLERININ KARISIMLARININ HAZIRLANMASI.
DE3480325D1 (en) Pharmaceutical dosage unit
FR2577422B1 (fr) Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine
Akman Hacettepe Bulletin of Medicine Surgery
ES292751U (es) Un elemento de union para la fijacion de tejidos oseos
JPS57175194A (en) 10b-carboxy-aminoboran and physiologically available salts of same, manufacture and use as neutron catching treatment medicine